Lemborexant On Track For Insomnia Market Entry
Pharma & Healthcare / Japan / Tue 23 Oct, 2018
Key View
- There will be a growing demand for insomnia therapeutics.
- An increasing prevalence and awareness of insomnia, plus unmet needs in its treatment, present a commercial opportunity for drugmakers.
- Orexin sleep aids have the potential to cause fewer side effects and Eisai/Purdue Pharma's lemborexant is a future growth driver in the